{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:53:46Z","timestamp":1791176026045,"version":"4.1.0"},"reference-count":29,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hereditary systemic amyloidosis caused by fibrinogen A\u03b1-chain gene mutations is an autosomal dominant condition with variable penetrance, usually of late onset, and typically presents with nephropathy leading to renal failure. Amyloid deposits often develop rapidly in transplanted kidneys, and concomitant orthotopic liver transplantation has lately been performed in several patients with the hope of halting amyloid deposition. Fibrinogen is produced in vitro by hepatocytes but also by other human cell types, and although the liver is the source of plasma fibrinogen in vivo in rats, this is not known in humans. Transplantation of livers expressing wild-type fibrinogen into patients with variant fibrinogen amyloidosis provides a unique opportunity to establish the source of human plasma fibrinogen. We therefore characterized plasma fibrinogen A\u03b1-chain allotypes by electrospray ionization mass spectrometry mapping of tryptic digests before and after liver transplantation. Before liver transplantation, fibrinogen amyloidosis patients with the Glu526Val A\u03b1-chain variant had approximately equal proportions of peptide with the wild-type sequence TFPGFFSPMLGEFVSETESR, and with the amyloidogenic variant sequence TFPGFFSPMLGEFVSVTESR, as expected for individuals heterozygous for the mutation. After transplantation, only the wild-type sequence was detected, and the liver is thus the source of at least 98% of the circulation fibrinogen.<\/jats:p>","DOI":"10.1182\/blood-2006-08-040956","type":"journal-article","created":{"date-parts":[[2006,11,2]],"date-time":"2006-11-02T22:18:19Z","timestamp":1162505899000},"page":"1971-1974","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":261,"title":["Human plasma fibrinogen is synthesized in the liver"],"prefix":"10.1182","volume":"109","author":[{"given":"Glenys A.","family":"Tennent","sequence":"first","affiliation":[{"name":"Centre for Amyloidosis & Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen O.","family":"Brennan","sequence":"additional","affiliation":[{"name":"Molecular Pathology Laboratory, Canterbury Health Laboratories, Christchurch Hospital, Christchurch, New Zealand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie J.","family":"Stangou","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies and Liver Transplant Services, King's College Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"O'Grady","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies and Liver Transplant Services, King's College Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Centre for Amyloidosis & Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Pepys","sequence":"additional","affiliation":[{"name":"Centre for Amyloidosis & Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2006,11,2]]},"reference":[{"key":"2019111714133783300_B1","doi-asserted-by":"crossref","unstructured":"Weisel JW. Fibrinogen and fibrin. Adv Protein Chem2005; 70:247\u2013299.","DOI":"10.1016\/S0065-3233(05)70008-5"},{"key":"2019111714133783300_B2","doi-asserted-by":"crossref","unstructured":"Miller LL, Bly CG, Watson ML, Bale WF. The dominant role of the liver in plasma protein synthesis: a direct study of the isolated perfused rat liver with the aid of lysine-\u03f5-C14. J Exp Med1951; 94:431\u2013453.","DOI":"10.1084\/jem.94.5.431"},{"key":"2019111714133783300_B3","doi-asserted-by":"crossref","unstructured":"Miller LL and Bale WF. Synthesis of all plasma protein fractions except gamma globulins by the liver: the use of zone electrophoresis and lysine-\u03f5-C14 to define the plasma proteins synthesized by the isolated perfused liver. J Exp Med1954; 99:125\u2013132.","DOI":"10.1084\/jem.99.2.125"},{"key":"2019111714133783300_B4","doi-asserted-by":"crossref","unstructured":"Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R. Hereditary renal amyloidosis associated with a mutant fibrinogen \u03b1-chain. Nat Genet1993; 3:252\u2013255.","DOI":"10.1038\/ng0393-252"},{"key":"2019111714133783300_B5","doi-asserted-by":"crossref","unstructured":"Uemichi T, Liepnieks JJ, Benson MD. Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest1994; 93:731\u2013736.","DOI":"10.1172\/JCI117027"},{"key":"2019111714133783300_B6","doi-asserted-by":"crossref","unstructured":"Uemichi T, Liepnieks JJ, Yamada T, Gertz MA, Bang N, Benson MD. A frame shift mutation in the fibrinogen A \u03b1-chain gene in a kindred with renal amyloidosis. Blood1996; 87:4197\u20134203.","DOI":"10.1182\/blood.V87.10.4197.bloodjournal87104197"},{"key":"2019111714133783300_B7","doi-asserted-by":"crossref","unstructured":"Uemichi T, Liepnieks JJ, Gertz MA, Benson MD. Fibrinogen A\u03b1 chain Leu 554: an African-American kindred with late onset renal amyloidosis. Amyloid: Int J Exp Clin Invest1998; 5:188\u2013192.","DOI":"10.3109\/13506129809003844"},{"key":"2019111714133783300_B8","unstructured":"Hamidi Asl L, Liepnieks JJ, Uemichi T, et al. Renal amyloidosis with a frame shift mutation in fibrinogen aalpha-chain gene producing a novel amyloid protein. Blood1997; 90:4799\u20134805."},{"key":"2019111714133783300_B9","doi-asserted-by":"crossref","unstructured":"Hamidi Asl L, Fournier V, Billerey C, et al. Fibrinogen A\u03b1 chain mutation (Arg554Leu) associated with hereditary renal amyloidosis in a French family. Amyloid: Int J Exp Clin Invest1998; 5:279\u2013284.","DOI":"10.3109\/13506129809007301"},{"key":"2019111714133783300_B10","doi-asserted-by":"crossref","unstructured":"Gillmore JD, Booth DR, Rela M, et al. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen \u03b1-chain variant in an English family. QJ Med2000; 93:269\u2013275.","DOI":"10.1093\/qjmed\/93.5.269"},{"key":"2019111714133783300_B11","doi-asserted-by":"crossref","unstructured":"Lachmann HJ, Booth DR, Booth SE, et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med2002; 346:1786\u20131791.","DOI":"10.1056\/NEJMoa013354"},{"key":"2019111714133783300_B12","doi-asserted-by":"crossref","unstructured":"de Carvalho M, Linke RP, Domingos F, et al. Mutant fibrinogen A-\u03b1-chain associated with hereditary renal amyloidosis and peripheral neuropathy. Amyloid: J Protein Folding Disord2004; 11:200\u2013207.","DOI":"10.1080\/13506120400000772"},{"key":"2019111714133783300_B13","doi-asserted-by":"crossref","unstructured":"Kang HG, Bybee A, Ha IS, et al. Hereditary amyloidosis in early childhood associated with a novel insertion-deletion (indel) in the fibrinogen A\u03b1 chain gene. Kidney Int2005; 68:1994\u20131998.","DOI":"10.1111\/j.1523-1755.2005.00653.x"},{"key":"2019111714133783300_B14","doi-asserted-by":"crossref","unstructured":"Zeldenrust S, Gertz M, Uemichi T, et al. Orthotopic liver transplantation for hereditary fibrinogen amyloidosis. Transplantation2003; 75:560\u2013561.","DOI":"10.1097\/01.TP.0000046526.10003.EC"},{"key":"2019111714133783300_B15","doi-asserted-by":"crossref","unstructured":"Stangou AJ, Lachmann HJ, Goodman HJB, et al. Fibrinogen A \u03b1-chain amyloidosis: clinical features and outcome after hepatorenal or solitary kidney transplantation. In Grateau G, Kyle RA, Skinner M (Eds.). Amyloid and Amyloidosis2005;Boca Raton, Florida CRC Press pp. 312\u2013314.","DOI":"10.1201\/9781420037494.ch105"},{"key":"2019111714133783300_B16","doi-asserted-by":"crossref","unstructured":"Mousson C, Heyd B, Justrabo E, et al. Successful hepatorenal transplantation in hereditary amyloidosis caused by a frame-shift mutation in fibrinogen A\u03b1-chain gene. Am J Transplant2006; 6:632\u2013635.","DOI":"10.1111\/j.1600-6143.2005.01199.x"},{"key":"2019111714133783300_B17","doi-asserted-by":"crossref","unstructured":"Stangou AJ and Hawkins PN. Liver transplantation in transthyretin-related familial amyloid polyneuropathy. Curr Opin Neurol2004; 17:615\u2013620.","DOI":"10.1097\/00019052-200410000-00012"},{"key":"2019111714133783300_B18","doi-asserted-by":"crossref","unstructured":"Holmgren G, Ericzon B-G, Groth C-G, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet1993; 341:1113\u20131116.","DOI":"10.1016\/0140-6736(93)93127-M"},{"key":"2019111714133783300_B19","doi-asserted-by":"crossref","unstructured":"Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem1998; 35:745\u2013753.","DOI":"10.1177\/000456329803500607"},{"key":"2019111714133783300_B20","doi-asserted-by":"crossref","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature1970; 227:680\u2013685.","DOI":"10.1038\/227680a0"},{"key":"2019111714133783300_B21","doi-asserted-by":"crossref","unstructured":"Brennan SO. Electrospray ionisation analysis of human fibrinogen. Thromb Haemost1997; 78:1055\u20131058.","DOI":"10.1055\/s-0038-1657686"},{"key":"2019111714133783300_B22","doi-asserted-by":"crossref","unstructured":"Holm B, Nilsen DW, Kierulf P, Godal HC. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res. 1985; 37:165\u2013176.","DOI":"10.1016\/0049-3848(85)90043-X"},{"key":"2019111714133783300_B23","doi-asserted-by":"crossref","unstructured":"Alper CA, Johnson AM, Birtch AG, Moore FD. Human C\u20323: evidence for the liver as the primary site of synthesis. Science1969; 163:286\u2013288.","DOI":"10.1126\/science.163.3864.286"},{"key":"2019111714133783300_B24","doi-asserted-by":"crossref","unstructured":"Hobart MJ, Lachmann PJ, Calne RY. C6: synthesis by the liver in vivo. J Exp Med1977; 146:629\u2013630.","DOI":"10.1084\/jem.146.2.629"},{"key":"2019111714133783300_B25","doi-asserted-by":"crossref","unstructured":"Alper CA, Raum D, Awdeh ZL, Petersen BH, Taylor PD, Starzl TE. Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, \u03b11-antitrypsin, C8, and factor B. Clin Immunol Immunopathol1980; 16:84\u201389.","DOI":"10.1016\/0090-1229(80)90169-5"},{"key":"2019111714133783300_B26","unstructured":"Schmeling A, Bockholdt B, Schroder H, Geserick G. Phenotype change in polymorphic plasma proteins following liver transplantation. Exp Clin Immunogenet1996; 13:78\u201383."},{"key":"2019111714133783300_B27","doi-asserted-by":"crossref","unstructured":"Raum D, Marcus D, Alper CA, Levey R, Taylor PD, Starzl TE. Synthesis of human plasminogen by the liver. Science1980; 208:1036\u20131037.","DOI":"10.1126\/science.6990488"},{"key":"2019111714133783300_B28","doi-asserted-by":"crossref","unstructured":"Naughton MA, Botto M, Carter MJ, Alexander GJM, Goldman JM, Walport MJ. Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J Immunol1996; 156:3051\u20133056.","DOI":"10.4049\/jimmunol.156.8.3051"},{"key":"2019111714133783300_B29","doi-asserted-by":"crossref","unstructured":"Pepys MB. Amyloidosis. Annu Rev Med2006; 57:223\u2013241.","DOI":"10.1146\/annurev.med.57.121304.131243"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/5\/1971\/1478894\/zh800507001971.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/5\/1971\/1478894\/zh800507001971.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T12:45:57Z","timestamp":1683636357000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/109\/5\/1971\/23235\/Human-plasma-fibrinogen-is-synthesized-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,2]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,11,2]]},"published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-08-040956","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,2]]}}}